755 related articles for article (PubMed ID: 19126566)
1. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of microvessel density and angiogenesis-related molecules in epithelial ovarian cancer].
Tan XJ; Lang JH; Lou WZ; Shen K; Xu XY
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):274-8. PubMed ID: 18788631
[TBL] [Abstract][Full Text] [Related]
4. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer.
Solomon LA; Munkarah AR; Schimp VL; Arabi MH; Morris RT; Nassar H; Ali-Fehmi R
Gynecol Oncol; 2006 Jun; 101(3):385-9. PubMed ID: 16443262
[TBL] [Abstract][Full Text] [Related]
5. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer.
Theodoropoulos VE; Lazaris ACh; Sofras F; Gerzelis I; Tsoukala V; Ghikonti I; Manikas K; Kastriotis I
Eur Urol; 2004 Aug; 46(2):200-8. PubMed ID: 15245814
[TBL] [Abstract][Full Text] [Related]
7. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY
Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737
[TBL] [Abstract][Full Text] [Related]
8. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with topoisomerase II alpha and prognosis.
Brustmann H
Gynecol Oncol; 2004 Oct; 95(1):16-22. PubMed ID: 15385105
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma.
Shen GH; Ghazizadeh M; Kawanami O; Shimizu H; Jin E; Araki T; Sugisaki Y
Br J Cancer; 2000 Jul; 83(2):196-203. PubMed ID: 10901370
[TBL] [Abstract][Full Text] [Related]
12. [Construction and utilization of the prognostic model of serous ovarian adenocarcinoma].
Yang R; Feng J; Fang XZ; Bai F; Cheng YX; Liu C; Zhu W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):459-63. PubMed ID: 17083811
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stage.
Brustmann H; Naudé S
Gynecol Oncol; 2002 Jan; 84(1):47-52. PubMed ID: 11748975
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma.
Li L; Liu B; Li X; Yang S; Xiao J; Chen M; Zhang Y; Ma J
Anat Rec (Hoboken); 2009 Apr; 292(4):562-9. PubMed ID: 19226617
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of measurements of angiogenesis in serous carcinoma of the ovary.
Palmer JE; Sant Cassia LJ; Irwin CJ; Morris AG; Rollason TP
Int J Gynecol Pathol; 2007 Oct; 26(4):395-403. PubMed ID: 17885489
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?
Duncan TJ; Al-Attar A; Rolland P; Scott IV; Deen S; Liu DT; Spendlove I; Durrant LG
Clin Cancer Res; 2008 May; 14(10):3030-5. PubMed ID: 18483368
[TBL] [Abstract][Full Text] [Related]
17. Ovarian serous carcinoma: relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression.
Crasta JA; Mishra S; Vallikad E
Int J Gynecol Pathol; 2011 Nov; 30(6):521-6. PubMed ID: 21979585
[TBL] [Abstract][Full Text] [Related]
18. Expression of hypoxia-inducible factor-1 alpha and its prognostic significance in small-sized adenocarcinomas of the lung.
Enatsu S; Iwasaki A; Shirakusa T; Hamasaki M; Nabeshima K; Iwasaki H; Kuroki M; Kuroki M
Eur J Cardiothorac Surg; 2006 Jun; 29(6):891-5. PubMed ID: 16675263
[TBL] [Abstract][Full Text] [Related]
19. Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer.
Suhonen KA; Anttila MA; Sillanpää SM; Hämäläinen KM; Saarikoski SV; Juhola M; Kosma VM
Eur J Cancer; 2007 May; 43(8):1300-7. PubMed ID: 17448653
[TBL] [Abstract][Full Text] [Related]
20. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
Sun LX; Wu Y; Han HQ; Wang QH
Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]